News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
University of Chicago Hematology/Oncology’s new Chief Fellow, Dr. Alexandra Rojek
Photo from University of Chicago Hematology/Oncology/X
Jul 11, 2024, 04:13

University of Chicago Hematology/Oncology’s new Chief Fellow, Dr. Alexandra Rojek

University of Chicago Hematology/Oncology shared on X:

“Welcome to our new Chief Fellow, Dr. Alexandra Rojek! We know she will do great things this year and are thrilled for her to be in this leadership role! Congratulations, Dr. Rojek!”

Source: University of Chicago Hematology/Oncology/X

Alexandra Rojek cancer Chief Fellow OncoDaily Oncology University of Chicago University of Chicago Hematology/Oncology
Insight
Aug 27, 2024, 03:50
Jose Debes: Right attitude to fight HPB cancers in Africa
Insight
Aug 27, 2024, 03:39
Shuchi Gulati: Sumanta K. Pal on the role of gut microbiome to optimize immunotherapy in cancer at CCCC24
Insight
Aug 27, 2024, 03:36
SIO - ASCO guidelines for treatment of common cancer symptoms
Insight
Aug 27, 2024, 03:29
David Lee: Awesome to be the host country for ESTRO meets Asia 2024
Insight
Aug 27, 2024, 03:25
Daniel Castellano: HABEMUS ESMO football 2024 tournament
Insight
Aug 27, 2024, 03:21
An open letter to policy makers: Effects of the climate crisis on cancer
Insight
Aug 27, 2024, 03:17
Understanding how cells communicate both spatially and temporally in an article by Liu et al.
Blog
Aug 27, 2024, 03:14
Sendurai Mani: How Monkeys Taught Me About Responsibility and Looking Beyond the Obvious
Insight
Aug 27, 2024, 03:11
Castalia Fernández: The molecular era of treatment of gliomas
Insight
Aug 27, 2024, 03:05
Ashish M. Kamat: Bladder-sparing Therapy for BCG–unresponsive NMIBC
Insight
Aug 27, 2024, 02:59
Anne Knisely: Metronidazole and Cefazolin for SSI prophylaxis in gynaecological surgery
Blog
Aug 26, 2024, 21:44
Tanja Obradovic: Can we expect new EGFR TKI to surpass osimertinib in primary tumor and intracranial progression of NSCLC